Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-15

Clinical Trial Update: Pregabalin for the Treatment of Vulvodynia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for pregabalin in treating vulvodynia and vulvar vestibulitis; study terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Vulvodynia, Vulvar Vestibulitis | Phase 2 | Status: TERMINATED | Results posted: 2017-05-15